|
Volumn 4, Issue 5, 2000, Pages 363-373
|
Immunoadsorption for the treatment of rheumatoid arthritis: Final results of a randomized trial
a,d b b c |
Author keywords
Double blind study; Immunoadsorption; Rheumatoid arthritis
|
Indexed keywords
ANTICOAGULANT AGENT;
ANTIRHEUMATIC AGENT;
DIPHENHYDRAMINE;
HEPARIN;
NONSTEROID ANTIINFLAMMATORY AGENT;
PARACETAMOL;
PREDNISONE;
STAPHYLOCOCCUS PROTEIN A;
ADULT;
ARTHRITIS;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE ACTIVITY;
DOUBLE BLIND PROCEDURE;
FATIGUE;
FEMALE;
HUMAN;
HYPOTENSION;
IMMUNOADSORPTION;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RHEUMATIC DISEASE;
RHEUMATOID ARTHRITIS;
TREATMENT OUTCOME;
ADULT;
ARTHRITIS, RHEUMATOID;
DOUBLE-BLIND METHOD;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOSORBENT TECHNIQUES;
MALE;
MIDDLE AGED;
PLACEBOS;
SAFETY;
TIME FACTORS;
|
EID: 0033746843
PISSN: 10916660
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1526-0968.2000.004005363.x Document Type: Conference Paper |
Times cited : (29)
|
References (21)
|